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〔目的〕 
Major histocompatibility complex (MHC) class I molecules present short peptides 
that are derived from endogenous proteins to T-cell receptors (TCRs) expressed on the 
surface of CD8
+
 T lymphocytes, forming the basis of MHC-restriction and antigen-
specific T-cell response. Soluble peptide/major histocompatibility complex (p/MHC) 
tetramers that directly bind to T cell receptors (TCRs) allow the direct quantification, 
phenotypic characterization and isolation of antigen-specific T cells. Soluble p/MHC 
tetramers have been conventionally produced using E. coli, but the method required 
high proficiency in molecular and biochemical techniques especially for refolding the 
recombinant proteins. To this end, we tried to generate functional p/MHC monomers by 
mammalian system, which does not require protein-refolding in vitro. 
 
〔方法並びに成績〕 
We constructed single-chain trimer DNA as follows: peptide-flexible linker-β2m-
flexible linker-heavy chain. To produce soluble SCT monomers, Expi293F cells were 
transfected with single-chain BRLF-1 (TYPVLEEMF)-HLA-A*24:02 (BRLF1-SCT)      
or      EBNA3A      (RYSIFFDYM)-HLA-A*24:02   (EBNA3A-SCT) 
expression vectors. The SCT monomers in the culture supernatant were then purified by 
ion exchange chromatography. The SCT monomers were tetramerized by the addition 
of phycoerythrin (PE)-conjugated streptavidin at a ratio of four molecules of monomer 
to one molecule of PE-conjugated streptavidin. We determined the BRLF-1 and 
EBNA3A-SCT tetramers can bind to the corresponding TCRs, BRLF-1-specific Q22 
TCR and EBNA3A-specific E21 TCR, respectively, by flow cytometry. To investigate 
whether the SCT monomer could activate the corresponding TCR-expressing T cell 
lines, we incubated Q22 or E21 TCR-transduced TG40 cells with various  
concentrations of plate-bound BRLF-1 and EBNA3A-SCT monomers. We found that 
plate-bound SCT monomers that were produced by this mammalian cell system could 
activate T cells in an antigen-dependent manner. In addition, we stimulated human 
peripheral blood lymphocytes from HLA-A24+ healthy donors, who were latently 
infected with EB virus, with the plate-coated SCT monomer in vitro. We found that the 
plate-coated SCT monomer vigorously induced antigen-specific T cells proliferation.  
To further characterize these antigen-specific T cells, we single cell-sorted these cells 
for TCR repertoire analysis and verified their specificity. These data demonstrated that 
 the plate-coated BRLF-1- and EBNA3A-SCT monomers can effectively induce the 
expansion of functional antigen-specific T cells in PBMCs. 
 
〔総括〕 
In this study, we developed a novel, simple, and high-throughput technology that 
enables us to produce large amounts of soluble SCT using a mammalian cell system that 
does not require protein refolding. This technique will provide a robust improvement in 
the technology such that the recombinant soluble p/MHC monomers and tetramers can 
be produced by any standard laboratory, which enables us to use them for analyzing 
antigen-specific T cells in basic and clinical studies. 
